https://www.selleckchem.com/pr....oducts/zunsemetinib.
46, 95% CI 0.24 to 0.9) but an increased risk of re-catheterization (RR 2.67, 95% CI 1.6 to 4.48). Significant differences in primary outcomes were found in the sub-comparison of ≤ 2days versus 2days. Three of six trials found a significantly shorter length of hospital stay in the early removal group. The results for postoperative pain were mixed. Among patients following pelvic organ prolapse surgery, early catheter removal is preferred. Moreover, the timing for removal is preferably within 2days postoperatively. Among patien
Aimer
Commentaire
Partagez
